These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33328754)

  • 1. Clinical Value of SARS-CoV2 IgM and IgG Antibodies in Diagnosis of COVID-19 in Suspected Cases.
    Feng Y
    J Inflamm Res; 2020; 13():1089-1094. PubMed ID: 33328754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of combined nucleic acid and antibody detection in suspected COVID-19 cases.
    Zeng H; Deng S; Zhou Z; Qiu X; Jia X; Li Z; Wang J; Duan H; Tu L; Wang J
    Public Health; 2020 Sep; 186():1-5. PubMed ID: 32731151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Nucleic Acid and Antibody Detection Results for SARS-CoV-2 Infection.
    Chen J; Niu Z; Li H; Tang D; Zhang P
    Arch Iran Med; 2021 May; 24(5):427-433. PubMed ID: 34196209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of combined detection of SARS-CoV-2-specific antibody and nucleic acid.
    Meng QB; Peng JJ; Wei X; Yang JY; Li PC; Qu ZW; Xiong YF; Wu GJ; Hu ZM; Yu JC; Su W
    World J Clin Cases; 2020 Oct; 8(19):4360-4369. PubMed ID: 33083395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value analysis of IgM and IgG antibodies detected by nucleic acid in patients with COVID-19.
    Ding T; Zhang N
    Am J Transl Res; 2021; 13(6):7089-7103. PubMed ID: 34306469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in serum virus-specific IgM/IgG antibody in asymptomatic and discharged patients with reoccurring positive COVID-19 nucleic acid test (RPNAT).
    Liu J; Lian R; Zhang G; Hou B; Wang C; Dong J; Yang L; Wang J; Dai S; Chen L; Zhang G; Lu X; Ye T
    Ann Med; 2021 Dec; 53(1):34-42. PubMed ID: 32808808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.
    Liu R; Liu X; Yuan L; Han H; Shereen MA; Zhen J; Niu Z; Li D; Liu F; Wu K; Luo Z; Zhu C
    Int Immunopharmacol; 2020 Sep; 86():106746. PubMed ID: 32619956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
    Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
    Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of an IgM and IgG Test for Diagnosis of Highly Suspected COVID-19.
    Jia X; Zhang P; Tian Y; Wang J; Zeng H; Wang J; Liu J; Chen Z; Zhang L; He H; He K; Liu Y
    Front Med (Lausanne); 2021; 8():569266. PubMed ID: 33912572
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of serology tests in COVID-19 non-hospitalized patients: A cross-sectional study.
    Haghi Ashtiani MT; Sadeghi Rad P; Asnaashari K; Shahhosseini A; Berenji F; Mamishi S
    PLoS One; 2022; 17(4):e0266923. PubMed ID: 35421183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of SARS-CoV-2 infections among children visiting a hospital.
    Wang R; Jin F; Cao S; Yuan H; Qu J; Zhang J; Li Y; Chen X; Song W; Xie Z
    Pediatr Investig; 2020 Dec; 4(4):236-241. PubMed ID: 33376950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.
    Guo CC; Mi JQ; Nie H
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10208-10218. PubMed ID: 33090430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
    Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A
    New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG.
    Gambino CM; Lo Sasso B; Colomba C; Giglio RV; Agnello L; Bivona G; Ciaccio M
    Biochem Med (Zagreb); 2020 Oct; 30(3):030901. PubMed ID: 33071558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19.
    Vengesai A; Midzi H; Kasambala M; Mutandadzi H; Mduluza-Jokonya TL; Rusakaniko S; Mutapi F; Naicker T; Mduluza T
    Syst Rev; 2021 May; 10(1):155. PubMed ID: 34039423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of Detection of Anti-SARS-CoV-2 IgG/IgM and SARS-CoV-2 RNA in Respiratory Tract Specimens in 48 COVID-19 Patients.
    Wu E; Zhang X; Zheng Y; Luo Z; Zhai W; Yin Z; Chen D; Wang Z; Zhai J; Han Y; Liu H; Li R; Wang Y; Feng Y; Shi G; Ma Y
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Joint Detection of Serum IgM/IgG Antibody Is an Important Key to Clinical Diagnosis of SARS-CoV-2 Infection.
    Hu F; Shang X; Chen M; Zhang C
    Can J Infect Dis Med Microbiol; 2020; 2020():1020843. PubMed ID: 33014210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.